Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved ...

A US vaccine advisory panel voted to stop recommending flu shots that contain thimerosal, a move that experts say may reduce access to vaccines.

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

The United States will stop sending money to Gavi, a global group that helps vaccinate children in low-income countries.

CagriSema vs placebo was associated with significant weight loss among adults with overweight or obesity with or without type ...

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.

The FDA has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

Individuals with MASLD with a lean vs nonlean body type have increased mortality and cardiovascular disease, among other outcomes.

A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.

GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...